JP-listed companies
Balance sheet

(4586) Balance sheet

Market cap

¥6.6B

P/E ratio

Medrex develops new pharmaceuticals using proprietary skin-patch delivery technology that improves drug effectiveness and reduces side effects.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	-	2,780	2,063	2,640	1,738	1,797	1,411	1,812	1,704	994	1,721	1,978	1,755
Total current assets	-	2,854	2,204	2,736	1,836	1,938	1,501	1,887	1,755	1,087	1,785	2,073	1,825
Property, plant and equipment, net	-	346	278	264	220	296	471	328	270	226	182	124	192
Marketable securities, non-current	-	414	417	-	-	-	-	-	-	-	-	31	131
Total non-current assets	-	831	774	343	297	374	547	410	354	311	267	203	333
Total assets	-	3,685	2,978	3,079	2,133	2,311	2,048	2,297	2,109	1,398	2,052	2,276	2,158
Short-term debt	-	-	-	-	-	-	-	50	-	-	-	-	-
Total current liabilities	-	79	110	103	89	170	116	123	126	158	100	106	77
Total non-current liabilities	-	92	96	469	10	11	11	27	27	27	28	-	31
Total liabilities	-	171	205	573	99	181	127	150	153	186	128	106	109
Retained earnings	-	-5,199	-6,078	-7,337	-8,221	-9,489	-11,105	-12,220	-13,280	-2,150	-916	-787	-899
Stockholders' equity	4,503	3,514	2,772	2,507	2,034	2,131	1,921	2,147	1,955	1,213	1,925	2,170	2,049